Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial

Published:2019-05 Issue:5 Volume:30 Page:757-765
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Trédan O.,Wang Q.,Pissaloux D.,Cassier P.,de la Fouchardière A.,Fayette J.,Desseigne F.,Ray-Coquard I.,de la Fouchardière C.,Frappaz D.,Heudel P.-E.,Bonneville-Levard A.,Fléchon A.,Sarabi M.,Guibert P.,Bachelot T.,Pérol M.,You B.,Bonnin N.,Collard O.,Leyronnas C.,Attignon V.,Baudet C.,Sohier E.,Villemin J.-P.,Viari A.,Boyault S.,Lantuejoul S.,Paindavoine S.,Treillleux I.,Rodriguez C.,Agrapart V.,Corset V.,Garin G.,Chabaud S.,Pérol D.,Blay J.-Y.^ORCID

Funder

Institut National du Cancer

INCa

LYRICAN

LYric

European Community

European Commission

Agence Nationale de la Recherche (ANR)-LabEx DEvweCAN

EURACAN

RREPS

InterSARC

Association DAM’s, Ensemble contre Le GIST

la Fondation ARC

Infosarcome

Ligue de l’Ain contre le Cancer

Centre Léon Bérard

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz080/28538573/mdz080.pdf

Reference20 articles.

1. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

2. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations;Hyman;N Engl J Med,2015

3. Tracking the evolution of non-small-cell lung cancer;Jamal-Hanjani;N Engl J Med,2017

4. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER);Andre;Lancet Oncol,2014

5. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade;McGranahan;Science,2016

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the “MOZART” prospective observational study;The Oncologist;2024-08-23

2. Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study;BMJ;2024-08-20

3. Next-generation sequencing in oncology: challenges in economic evaluations;Expert Review of Pharmacoeconomics & Outcomes Research;2024-08-11

4. Role of molecular biology in the management of pancreatic cancer;World Journal of Gastrointestinal Oncology;2024-07-15

5. Clinical Utility of Tumor Next-Generation Sequencing Panel Testing to Inform Treatment Decisions for Patients With Advanced Solid Tumors in a Tertiary Care Center;JCO Precision Oncology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3